Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Elucidating the role of reactive oxygen species (ROS) in the progression of Alzheimer’s Disease (AD) using a transgenic rat model

EF 2015-16

Résumé
Alzheimer's disease (AD) is the leading cause of dementia and there is currently no cure nor effective therapeutics for AD. It is becoming widely accepted that AD begins decades before clinical symptoms appear. As such, early intervention before the brain has suffered irreversible damage, is key to halting progression of AD. Presently, the pre-symptomatic stages of AD are not well understood and in order to develop promising therapeutics, further research is needed. Transgenic mice and rat models that exhibit AD-like pathology have proven to be essential in better understanding progression of AD. Using these models, it has been discovered that inflammatory processes precede plaque deposition and favour disease progression. Importantly, inflammation and oxidative stress are tightly interconnected in later stages of AD in both animal models and AD patients. However, less is known on the presence and significance of oxidative stress products at early pathological stages. This project aims to investigate pre-symptomatic progression of AD and hypothesizes that oxidative stress drives or at least accompanies neuronal inflammation in the early stages of AD. The project involves detecting ROS in fresh hippocampal tissue and mitochondria of transgenic rats exhibiting the AD-like pathology. The hippocampus is essential for memory formation and mitochondrial dysfunction has been observed in late stages of AD. Novel probes will be used in these systems that react with ROS and fluoresce, allowing for reliable measurement of oxidative stress. By gaining an understanding of the cellular mechanisms occurring in the brain before development of AD, preventative therapeutics can be made to hinder disease progression and disease promoting events.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
349956
Name
Foret Morgan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the role of reactive oxygen species (ROS) in the progression of Alzheimer’s Disease (AD) using a transgenic rat model
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Amyloid; Early Pathology; Inflammation; Mitochondrial Dysfunction; Oxidative Stress; Pre-Clinical; Transgenic Rat Model
Abstract
Alzheimer's disease (AD) is the leading cause of dementia and there is currently no cure nor effective therapeutics for AD. It is becoming widely accepted that AD begins decades before clinical symptoms appear. As such, early intervention before the brain has suffered irreversible damage, is key to halting progression of AD. Presently, the pre-symptomatic stages of AD are not well understood and in order to develop promising therapeutics, further research is needed. Transgenic mice and rat models that exhibit AD-like pathology have proven to be essential in better understanding progression of AD. Using these models, it has been discovered that inflammatory processes precede plaque deposition and favour disease progression. Importantly, inflammation and oxidative stress are tightly interconnected in later stages of AD in both animal models and AD patients. However, less is known on the presence and significance of oxidative stress products at early pathological stages. This project aims to investigate pre-symptomatic progression of AD and hypothesizes that oxidative stress drives or at least accompanies neuronal inflammation in the early stages of AD. The project involves detecting ROS in fresh hippocampal tissue and mitochondria of transgenic rats exhibiting the AD-like pathology. The hippocampus is essential for memory formation and mitochondrial dysfunction has been observed in late stages of AD. Novel probes will be used in these systems that react with ROS and fluoresce, allowing for reliable measurement of oxidative stress. By gaining an understanding of the cellular mechanisms occurring in the brain before development of AD, preventative therapeutics can be made to hinder disease progression and disease promoting events.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Foret, Morgan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~